Chemical Structure (Gabapenin 01)
Gabapentin Tablet, Coated
Product Images NDC 50090-7268
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-7268). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Gabapenin 02)
This text provides information about a study or trial involving a comparison of mean pain scores between a placebo group and a group taking Gabapentin at a dosage of 3,600 mg/day over a 4-week period. The data includes time points from baseline to week 8.*
Figure 2 (Gabapenin 03)
This is a chart showing Mean Pain Score for different dosage levels of Gabapentin over a study period that includes a 3-week dose titration period followed by a 4-week fixed dose period. The chart compares the effects of Placebo, Gabapentin 1,800 mg/day, and Gabapentin 2,400 mg/day on pain levels. The numbers 1 to 6 along the bottom indicate time points or assessment intervals.*
Figure 3 (Gabapenin 04)
This data likely pertains to a study or experiment where percentages are reported. The text includes different percentage values ranging from 0% to 100%. There are also mentions of statistical significance levels such as ** p<0.01 and *** p<0.001. The data seems to be split into different studies, with Study 1 and Study 2 being referenced along with specific percentage values for each study. The presence of "PBO" suggests that some form of control or placebo group may have been involved in the studies.*
Figure 4 (Gabapenin 05)
Label Image (Lbl500907268)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
